Group 1 - The board meeting of HuTongDa Network (09878.HK) is scheduled for March 30, 2026, to consider and approve the company's and its subsidiaries' full-year performance for the year ending December 31, 2025, and its release [1] - The meeting will also consider the proposal for the distribution of a final dividend, if any [1]

Group 1 - The company, Evergrande Property (06666.HK), announced that it will hold a board meeting on March 27, 2026, to consider and approve the annual performance for the year ending December 31, 2025, and to discuss the potential distribution of a final dividend, if any [1]

Group 1 - The company, Anton Oilfield Services (03337.HK), announced that it will hold a board meeting on March 29, 2026, to consider and approve the annual performance for the year ending December 31, 2025, along with its release [1] - The board meeting will also consider the distribution of a final dividend, if any [1]

Group 1 - The company, Esprit Holdings Limited (00330.HK), announced a board meeting scheduled for March 30, 2026, to consider and approve the annual results for the year ending December 31, 2025, and to discuss the potential distribution of a final dividend, if any [1]

Group 1 - The company, Lixin International (00191.HK), will hold a board meeting on March 27, 2026, to consider and approve the unaudited interim results for the six months ending January 31, 2026, as well as the declaration of an interim dividend if applicable [1]

Core Viewpoint - Fuyao Glass (600660.SH) reported a significant increase in revenue and profit for the year 2025, indicating strong financial performance and growth potential in the glass manufacturing industry [1] Financial Performance - The company achieved a consolidated operating revenue of RMB 45.787 billion, representing a year-on-year growth of 16.65% [1] - The total profit reached RMB 11.162 billion, marking a 24.15% increase compared to the previous year [1] - The net profit attributable to shareholders was RMB 9.312 billion, reflecting a growth of 24.20% year-on-year [1] - Earnings per share (EPS) stood at RMB 3.57, which is a 24.39% increase from the prior year [1] Dividend Distribution - The company plans to distribute a cash dividend of RMB 1.20 per share (including tax) to A-share and H-share shareholders based on the total number of shares registered on the dividend distribution date for 2025 [1] - The remaining undistributed profits will be carried forward to the next fiscal year [1]

格隆汇3月17日丨丽新发展(00488.HK)公布，公司将于2026年3月27日(星期五)举行董事会会议，以考虑 并批准(其中包括)公司及其附属公司截至2026年1月31日止六个月之未经审核中期业绩之公布以及宣派 中期股息(如适用)。 ...

格隆汇3月17日丨香港科技探索(01137.HK)宣布，将于2026年3月30日（星期一）举行董事会会议，藉以 （其中包括）批准公司及其附属公司截至2025年12月31日止年度的全年业绩公告发布，以及考虑建议派 发截至2025年12月31日止年度的末期股息（如有）。 ...

Core Viewpoint - China National Pharmaceutical Group (01177.HK) announced that its subsidiary Beijing Tide Pharmaceutical Co., Ltd. has received clinical trial approval from the National Medical Products Administration (NMPA) for its innovative drug TRD221, a complement protein modulator intended for the treatment of osteoarthritis [1]. Group 1 - The drug TRD221 is classified as a national Class 1 innovative drug [1]. - The approval from NMPA marks a significant milestone for the company in its drug development pipeline [1]. - The intended use of TRD221 is specifically for osteoarthritis, indicating a focus on addressing this prevalent condition [1].

Group 1 - The company GAC Group (02238.HK) announced that its board meeting will be held on March 27, 2026, to consider and approve the annual results for the year ending December 31, 2025, and to discuss the proposed final dividend distribution, if any [1]